High calcium diet down-regulates kidney angiotensin-converting enzyme in experimental renal failure

Kidney Int. 2004 Dec;66(6):2155-66. doi: 10.1111/j.1523-1755.2004.66006.x.

Abstract

Background: Calcium salts are used as phosphate binders in renal failure, while high calcium diet also improves vasorelaxation and enhances natriuresis. The influences of calcium intake on renal renin-angiotensin system (RAS) are largely unknown.

Methods: Four weeks after NTX, rats were put on 3.0% or 0.3% calcium diet for 8 weeks (12-week study). In additional experiments, 15 weeks after NTX, rats were put on similar diets for 12 weeks (27-week study). Appropriate blood, urine, and kidney samples were taken. Renal angiotensin-converting enzyme (ACE) and angiotensin II receptors (AT1, AT2) were examined using autoradiography, ACE also using Western blotting, and connective tissue growth factor (CTGF) using immunohistochemistry.

Results: In the 12-week study, albuminuria increased 5-fold in NTX rats, but only 2-fold in calcium NTX rats on 3.0% calcium. In the 27-week study, high calcium intake decreased blood pressure, retarded progression of renal failure, reduced glomerulosclerosis, interstitial damage, and aortic calcifications, and improved survival from 50% to 92% in NTX rats. In both experiments plasma parathyroid hormone and phosphate were elevated after NTX, and suppressed by high calcium diet, while kidney ACE was down-regulated by 40% or more after increased calcium intake. In the 27-week study renal CTGF was decreased and cortical AT1 receptor density reduced after high calcium diet.

Conclusion: High calcium diet down-regulated kidney ACE, reduced albuminuria and blood pressure, and favorably influenced kidney morphology in experimental renal failure. These findings suggest a link between calcium metabolism and kidney ACE expression, which may play a role in the progression of renal damage.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Albuminuria / drug therapy*
  • Albuminuria / metabolism
  • Albuminuria / pathology
  • Animals
  • Aorta / pathology
  • Calcium, Dietary / pharmacology*
  • Connective Tissue Growth Factor
  • Down-Regulation / drug effects
  • Immediate-Early Proteins / metabolism
  • Intercellular Signaling Peptides and Proteins / metabolism
  • Kidney / enzymology*
  • Kidney / pathology
  • Male
  • Parathyroid Hormone / blood
  • Peptidyl-Dipeptidase A / metabolism*
  • Phosphates / blood
  • Rats
  • Rats, Sprague-Dawley
  • Renal Insufficiency / drug therapy*
  • Renal Insufficiency / metabolism
  • Renal Insufficiency / pathology
  • Renin-Angiotensin System / drug effects
  • Renin-Angiotensin System / physiology

Substances

  • CCN2 protein, rat
  • Calcium, Dietary
  • Immediate-Early Proteins
  • Intercellular Signaling Peptides and Proteins
  • Parathyroid Hormone
  • Phosphates
  • Connective Tissue Growth Factor
  • Peptidyl-Dipeptidase A